On 30 June 2020, the board of directors of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. received the resignation letter from Ms. Mu Haining, a non-executive Director, to resign as a non-executive Director and cease to be a member of the audit committee, the nomination committee and the remuneration and appraisal committee of the Board due to change in work arrangement. In accordance with the articles of association of the Company, the resignation of Ms. Mu Haining shall become effective from 30 June 2020. The company announced that at the annual general meeting of the company convened on 30 June 2020, Mr. Gong Ping and Mr. Pan Donghui were duly elected by the Shareholders as non-executive Directors of the eighth session of the Board. Gong Ping has been appointed as a member of the audit committee of the Board, Pan Donghui has been appointed as a member of the nomination committee and the remuneration and appraisal committee of the Board.